Approximately 90% of neuroblastomas express the norepinephrine transporter (NET) [3], enabling the application of meta-iodobenzylguanidine (MIBG), a structural analog of norepinephrine, for imaging and treatment purposes (Fig. 1). Here, SLC6A2 is linked to neuroblastoma.